← Search & browse all drugs
GENITO URINARY SYSTEM AND SEX HORMONES › SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM › HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE › Progestogens and estrogens, fixed combinations
drospirenone and estetrol
G03AA18
Forms & Strengths
- Tablet: drospirenone 3 mg and estetrol 1.5 mg
- Tablet: drospirenone 3 mg and estetrol 1 mg
- Tablet: drospirenone 3 mg and estetrol 2 mg
- Tablet: drospirenone 3 mg and estetrol 2.5 mg
- Tablet: drospirenone 3 mg and estetrol 3 mg
- Tablet: drospirenone 3 mg and estetrol 4 mg
Adult Dosing
- 1 tablet orally once daily
- Take at the same time every day
- Start on Day 1 of menstrual cycle
- Missed dose: take as soon as remembered, then continue with regular schedule
Pediatric Dosing
- Not recommended under 18 years
- No established use in pediatric population
Indications
- Oral contraception
- Treatment of heavy menstrual bleeding
- Treatment of symptoms of premenstrual dysphoric disorder
Mechanism of Action
- Drospirenone: antiandrogenic and progestogenic activity
- Estetrol: estrogenic activity, selective estrogen receptor modulator
- Inhibits ovulation by suppressing luteinizing hormone surge
Contraindications
- Known or suspected pregnancy
- Breast cancer or other estrogen- or progestin-sensitive cancer
- Undiagnosed abnormal uterine bleeding
- Liver tumors, acute liver disease, or liver dysfunction
- Hypersensitivity to drospirenone or estetrol
Adverse Reactions
- Nausea, vomiting, diarrhea
- Headache, dizziness, fatigue
- Mood changes, including depression and anxiety
- Breast tenderness, changes in libido
- Increased risk of blood clots and stroke
Drug Interactions
- Inducers of CYP3A4: potential decreased efficacy of drospirenone and estetrol
- Inhibitors of CYP3A4: potential increased levels of drospirenone and estetrol
- Concomitant use with St. John's Wort: potential decreased efficacy
- Concomitant use with anticoagulants: potential increased risk of thromboembolism
Curated Content: Needs Vetting Before Put to Clinical Use